Wall Street Journal -
24 Oct 2015 06:24
Of investors' many concerns about Valeant Pharmaceuticals and its relationship with a specialty pharmacy, one has stood out: Why is Valeant talking about this only now? Until this week, Valeant's disclosures on the subject were slim.
Share this Article